Should Phage Therapy Be Approved in the U.S.?
PubblicoPhage therapy is the use of viruses to lyse bacteria. The technique has the potential for treating antibiotic-resistant bacterial infections, an increasing threat to our healthcare system. The goal of this IQP project was to evaluate phage therapy technology by assessing its technical, ethical, and regulatory problems, to help determine whether it should be approved for use in the U.S. Our team performed a review of the research literature, and conducted interviews with academic researchers, workers in phage companies, regulatory experts, and bioethicists. We conclude that the technology has great potential, but the methods used need to be standardized, precautions need to be enacted, and more controlled clinical trials need to be performed.
- This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.
- Creator
- Subject
- Publisher
- Identifier
- E-project-081716-120707
- Parola chiave
- Advisor
- Year
- 2016
- Date created
- 2016-08-17
- luogo
- Worcester
- Resource type
- Rights statement
Relazioni
- In Collection:
Articoli
Elementi
Thumbnail | Titolo | Visibilità | Embargo Release Date | Azioni |
---|---|---|---|---|
|
8-17-16__Phage_Therapy_IQP_Final_Report.pdf | Pubblico | Scaricare |
Permanent link to this page: https://digital.wpi.edu/show/8c97kq99v